Gastrointestinal Symptoms clinical trials

Explore recruiting gastrointestinal symptoms clinical trials.

Recruiting gastrointestinal symptoms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastrointestinal Symptoms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, placebo-controlled trial to assess the efficacy, tolerability, and pharmacokinetics of clemastine in children and adults with Pitt-Hopkins syndrome

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

An open label safety and efficacy study of allogenic adipose tissue-derived mesenchymal stromal cells on autism and gastrointestinal symptoms

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

FELICITA - A proof of concept study: open label phase IIa trial evaluating the effect and safety of transplantation of fecal microbiota in children with autism spectrum disorders and gastrointestinal symptoms

France

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, multicenter, prospective, single-arm, exploratory study to assess role of pancreatic enzyme replacement therapy (PERT) (Creon® 25,000) in patients with Pancreatic Exocrine Insufficiency (PEI) after total gastrectomy.

Portugal, Poland, Spain

Therapeutic use (Phase IV) EU CTIS Study details

Effect of faecal microbiota transplant on the expression of autism spectrum disorder core symptoms in children – open-label phase II clinical trial (FMT-PAS)

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A prospective, randomized, double-blind, placebo-controlled Phase I/IIa Clinical Trial to demonstrate the safety and efficacy of DUOFAG® in bacterial infection treatment in patients with surgical wounds

Czechia

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Gastrointestinal Symptoms trials by city

Gastrointestinal Symptoms in Toronto Gastrointestinal Symptoms in Vancouver Gastrointestinal Symptoms in Montreal Gastrointestinal Symptoms in Calgary Gastrointestinal Symptoms in Edmonton Gastrointestinal Symptoms in Ottawa Gastrointestinal Symptoms in Winnipeg Gastrointestinal Symptoms in Quebec City Gastrointestinal Symptoms in Hamilton Gastrointestinal Symptoms in Kitchener Gastrointestinal Symptoms in London Gastrointestinal Symptoms in Halifax Gastrointestinal Symptoms in New York Gastrointestinal Symptoms in Los Angeles Gastrointestinal Symptoms in Chicago Gastrointestinal Symptoms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease